SCHEMBL5357408

SCHEMBL5357408

CC[Si](CC)(CC)OC(C1CCC(N(Cc2ccccc2)CC2CC2)CC1)(C(F)(F)F)C(F)(F)F

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 4/20 0.39
SLC6A4 P31645 4/20 0.39
LTA4H P09960 1/20 0.37
GRIN2B Q13224 1/20 0.37
KMT2A Q03164 3/20 0.34
MEN1 O00255 1/20 0.34
RAB9A P51151 1/20 0.34
DPP4 P27487 2/20 0.33
DPP9 Q86TI2 2/20 0.33
DPP7 Q9UHL4 2/20 0.33
DPP8 Q6V1X1 1/20 0.33
YTHDC1 Q96MU7 1/20 0.33
DRD2 P14416 2/20 0.32
DRD3 P35462 1/20 0.32
NR1H2 P55055 1/20 0.32
NR1H3 Q13133 1/20 0.32
NPBWR1 P48145 1/20 0.31
MCHR1 Q99705 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5353509 0.82 NR1H2 (0.38) SLC6A2SLC6A4NR1H2NR1H3
SCHEMBL5355490 0.77 SLC6A2 (0.44) SLC6A2SLC6A4LTA4HGRIN2BKMT2A
SCHEMBL5348999 0.77 ACHE (0.44) GRIN2BKMT2AMEN1RAB9A
SCHEMBL5347919 0.77 ACHE (0.44) GRIN2BKMT2AMEN1RAB9A
SCHEMBL5614293 0.73 SLC6A2 (0.45) SLC6A2SLC6A4LTA4HGRIN2BKMT2A
SCHEMBL5352146 0.70 DRD2 (0.43) DRD2DRD3NR1H2
SCHEMBL24424078 0.69 YTHDC1 (0.48) SLC6A2SLC6A4GRIN2BKMT2AMEN1
SCHEMBL18828701 0.69 LTA4H (0.59) SLC6A2SLC6A4LTA4HKMT2AMEN1
SCHEMBL1461945 0.69 GRIN2B (0.48) SLC6A2SLC6A4LTA4HGRIN2BKMT2A
SCHEMBL21222467 0.68 NR1H2 (0.43) SLC6A2SLC6A4GRIN2BKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831158-A1 NOVEL CYCLOHEXANE DERIVATIVES F. Hoffmann-Roche AG (CH) 2007-09-12 EP disclosed
US-7253282-B2 Hexafluoroisopropanol substituted cyclohexane derivatives HOFFMAN-LA ROCHE INC. (US) 2007-08-07 US disclosed
WO-2006066779-A1 NOVEL CYCLOHEXANE DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2006-06-29 WO disclosed
US-20060135601-A1 Novel hexafluoroisopropanol substituted cyclohexane derivatives HOFFMANN-LA ROCHE INC. 2006-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060135601-A1 Novel hexafluoroisopropanol substituted cyclohexane derivatives NR1H3, NR1H2, NR1I2 SLC6A2 3185/4885SLC6A4 2782/4885LTA4H 1184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.